Hald, Øyvind Holsbø
4  results:
Search for persons X
?
2

Molecular aspects of high-risk neuroblastoma and novel ther..:

Hald, Øyvind Holsbø
Paper 1: Hald, Ø.H., Olsen, L., Gallo-Oller, G., Elfman, L.H.M., Løkke, C., Kogner, P., … Einvik, C. (2019). Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma. Oncogene, 38 , 2800–2813. Also available in Munin at https://hdl.handle.net/10037/18268 . Paper 2: Roth, S.A., Hald, Ø.H., Fuchs, S., Løkke, C., Mikkola, I., Flægstad, T., Schulte, J. & Einvik, C. (2018). MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN. Oncotarget, 9 , 18160-18179. Also available in Munin at https://hdl.handle.net/10037/18270 . Paper 3: Haug, B.H., Hald, Ø.H., Utnes, P., Roth, S.A., Løkke, C., Flægstad, T. & Einvik, C. (2015). Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs. Anticancer Research, 35 (5), 2521-2530. Also available in Munin at https://hdl.handle.net/10037/18269 ..  , 2020
 
?
3

MicroRNA-193b-3p represses neuroblastoma cell growth via do..:

Roth, Sarah Andrea ; Hald, Øyvind Holsbø ; Fuchs, Steffen...
Hald, Ø.H. (2020). Molecular aspects of high-risk neuroblastoma and novel therapeutic opportunities. (Doctoral thesis). https://hdl.handle.net/10037/18271 ..  , 2018
 
?
4

Inhibitors of ribosome biogenesis repress the growth of MYC..:

Hald, Øyvind Holsbø ; Olsen, Lotte ; Gallo-Oller, Gabriel...
Hald, Ø.H. (2020). Molecular aspects of high-risk neuroblastoma and novel therapeutic opportunities. (Doctoral thesis). https://hdl.handle.net/10037/18271 ..  , 2018
 
1-4